Adage Capital Partners’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200,000
Closed -$9.32M 1055
2022
Q3
$9.32M Buy
+200,000
New +$9.28M 0.02% 658
2020
Q3
Sell
-45,000
Closed -$5.38M 825
2020
Q2
$5.38M Sell
45,000
-55,000
-55% -$6.52M 0.01% 612
2020
Q1
$10M Sell
100,000
-120,000
-55% -$14.4M 0.03% 467
2019
Q4
$25.9M Sell
220,000
-30,000
-12% -$2.97M 0.06% 329
2019
Q3
$21.5M Sell
250,000
-250,000
-50% -$18.9M 0.05% 350
2019
Q2
$32.4M Sell
500,000
-200,000
-29% -$12.5M 0.08% 271
2019
Q1
$43.8M Buy
700,000
+592,500
+551% +$27.9M 0.11% 219
2018
Q4
$4.18M Buy
+107,500
New +$4.78M 0.01% 622
2018
Q3
Sell
-200,000
Closed -$16M 768
2018
Q2
$16M Buy
200,000
+75,000
+60% +$6.22M 0.04% 461
2018
Q1
$10.8M Buy
+125,000
New +$10.1M 0.03% 542
2017
Q4
Sell
-150,000
Closed -$13.6M 759
2017
Q3
$13.6M Buy
+150,000
New +$12.8M 0.03% 502
2017
Q2
Sell
-30,000
Closed -$2.81M 762
2017
Q1
$2.81M Buy
+30,000
New +$2.72M 0.01% 651
2015
Q2
Sell
-120,417
Closed -$5.77M 772
2015
Q1
$5.77M Sell
120,417
-60,000
-33% -$2.6M 0.01% 617
2014
Q4
$6.98M Buy
+180,417
New +$5.68M 0.02% 589

Other funds holding NVRO

Adage Capital Partners's NVRO Position: Q4 2022 in Review

Adage Capital Partners sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 200,000 shares — an estimated $9.32M sold.

Adage Capital Partners first reported a position in NVRO in Q4 2014 and held it in 14 quarters. The position peaked at $43.8M in Q1 2019. 169 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • Adage Capital Partners reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • Adage Capital Partners sold 200,000 NEVRO CORP. shares in Q4 2022, an estimated $9.32M.
  • Adage Capital Partners first reported a position in NEVRO CORP. in Q4 2014 and held it in 14 quarters.
  • Adage Capital Partners's NEVRO CORP. position peaked at $43.8M in Q1 2019.
  • 169 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Adage Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.